Saturn Biosciences Ltd logo

Saturn Biosciences Ltd

Saturn Biosciences is focused on developing SAT012 (fka AS-1409), a clinical stage asset, to address the huge market of oncology patients not responding to checkpoint inhibitors.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttp://www.saturn-biosciences.com
Founded2009
Disease Focus
Development Stage
STOCK CODENon Listed
Address
77 West Drive, Highfields Caldecote, CB23 7RY
Cambridge
United Kingdom
Email
Contact Number

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/saturn-biosciences-ltd” connections=”true” suffix=””]